The DOI matches its Crossref record; 78 of the 79 references it cites were found in a registry or an index.
Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges
Abstract
Probiotic bacteria are used to treat disturbed intestinal microflora and increased gut permeability which are characteristic to many intestinal disorders. Examples include children with acute rotavirus diarrhoea, subjects with food allergy, subjects with colonic disorders and patients undergoing pelvic radiotherapy and sometimes changes associated with colon cancer development. In all such disease states altered intestinal microflora, impaired gut barrier and different types of intestinal inflammation are present. Successful probiotic bacteria are able to survive gastric conditions and colonize the intestine, at least temporarily, by adhering to the intestinal epithelium. Such probiotic microorganisms appear to be promising candidates for the treatment of clinical conditions with abnormal gut microflora and altered gut mucosal barrier functions. They are also promising ingredients to future functional foods and clinical foods for specific disease states provided that basic requirements for strains and clinical studies are carefully followed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These findings are reminiscent of clinical findings with VSL#3 therapy, which suggest that it is most helpful in treatment of patients with ulcerative colitis during the early phase of the disease (27,28).”
From Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip (2016) · cites this paper as [27]
In the citing paper
“As probiotics have been reported in several studies to restore the intestinal microbiota and gut barrier as well as hinder bacterial translocation, the therapeutic potential of probiotics in IBS has become of strong interest.10,11”
Citations
Cites
Podolsky, D. K. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109263251306 · Cited by 1,231
Saavedra, J. M., Bauman, N. A., Perman, J. A., Yolken, R. H., Saavedra, J. M., Bauman, N. A., & Oung, I. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91708-6 · Cited by 970
Bernet, M. F., Brassart, D., Neeser, J. R., & Servin, A. L. (1994) · Gut · doi:10.1136/gut.35.4.483 · Cited by 751
Food hypersensitivity and atopic dermatitis: Evaluation of 113 patients
Sampson, H. A., & McCaskill, C. C. (1985) · The Journal of Pediatrics · doi:10.1016/s0022-3476(85)80390-5 · Cited by 717
Kaila, M., Isolauri, E., Soppi, E., Virtanen, E., Laine, S., & Arvilommi, H. (1992) · Pediatric Research · doi:10.1203/00006450-199208000-00002 · Cited by 700 · cited 2×
“Different lactic acid bacteria were compared for their effects on the immune response to rotavirus in children with acute rotavirus gastroenteritis (Kaila et al., 1992; Majamaa et al., 1995).”
BackgroundSelf-citationIsolauri, E., Juntunen, M., Rautanen, T., Sillanaukee, P., & Koivula, T. (1991) · PubMed · Cited by 684
Self-citationSurvival ofLactobacillus species (strain GG) in human gastrointestinal tract
Goldin, B. R., Gorbach, S. L., Saxelin, M., Barakat, S., Gualtieri, L., & Salminen, S. (1992) · Digestive Diseases and Sciences · doi:10.1007/bf01308354 · Cited by 554
Self-citationLactic Acid Bacteria in the Treatment of Acute Rotavirus Gastroenteritis
Majamaa, H., Isolauri, E., Saxelin, M., & Vesikari, T. (1995) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.1995.tb11561.x · Cited by 552
Self-citationThe coming of age of probiotics
Lee, Y.-K., & Salminen, S. (1995) · Trends in Food Science & Technology · doi:10.1016/s0924-2244(00)89085-8 · Cited by 540
Self-citationGillen, C. D., Walmsley, R. S., Prior, P., Andrews, H. A., & Allan, R. N. (1994) · Gut · doi:10.1136/gut.35.11.1590 · Cited by 516 · cited 1×
“Both the relative risk and the cumulative incidences of cancer were the same ( Gillen et al., 1994 ).”
Background
Research works printed but not linked: 13
- Casas I, Shornikova A, Isolauri E, Salminen S, Vesikari T (1996) Colonization of Lactobacillus reuteri in the gastrointestinal tract of children. Abstracts of the SOMED Meeting, Puerto Rico 1995. Micr. Ecol. Health Dis.. (in press)
- Friberg L-G (1980) Effects of irradiation on the small intestine of the rat. A SEM study. Ph.D. Thesis, University of Lund, Lund, Sweden
- Gasser F (1994) Safety of lactic acid bacteria and their occurrence in human clinical infections. Bull Inst. Pasteur. 92: 45?67
- Isolauri E (1995) Intestinal Integrity and IBD. Kluwer Academic Publishers, Lancaster, UK, 85: 553?5
- Salminen E, Salminen S, Vapaatalo H & Holsti LR (1995) Adverse effects of pelvic radiotherapy. International Meeting on Progress in Radio-oncology, HD Kogelnik (ed.,) (pp 501?504) Monduzzi Editore, Italy
- Salminen S, Deighton M, Gorbach SL (1993) Lactic acid bacteria in health and disease. In: Salminen S & von Wright A (Eds) Lactic Acid Bacteria (pp 199?225). Marcel Dekker Inc, New York
- Sawamura A, Yamaguchi Y, Toge T, Nagata N, Ikeda H, Nakanishi K, Asakura A (1994). The enhancing effect of oral Lactobacillus casei on the immunologic acitivty of colon cancer patients. Biotherapy 8: 1567?1572
- Saxelin M, Elo S, Salminen S & Vapaatalo H (1991) Dose response colonisation of faeces after oral administration of Lactobacillus casei strain GG. Micr. Ecol. Health Dis. 4: 209?214
- Silva C (1993) The use of elemental diets in radiation enteritis. In: Bounous G (Ed)., Uses of elemental diets in clinical situations (pp 122?134). CRC Press, Boca Raton, FL, USA
- Strobel S (1991) Mechanisms of gastrointestinal immunoregulation and food induced injury. Eur J. Clin. Nutr. 45: 1?9
- Sugita T, Togawa M. (1994). Efficacy of Lactobacillus preparation Biolactis powder in children with rotavirus enteritis. Japan J. Pediatr. 47: 2755?2762
- Sütas Y, Hurme M & Isolauri E (1996) Differential regulation of cytokine production by bovine caseins: evidence for generation of tolerogens from allergens by intestinal bacteria. Scand. J. Immunol. (in press)
- Tanaka R & Ohwaki M (1994) A controlled study on the ingestion of Lactobacillus casei fermented milk on the intestinal microflora, its microbiology and immune system in healthy adults. Proceedings of XII Riken Symposium on Intestinal Flora, Tokyo, Japan, 85?104
Cited by
Probiotic Bacteria as Biological Control Agents in Aquaculture
Verschuere, L., Rombaut, G., Sorgeloos, P., & Verstraete, W. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.4.655-671.2000 · Cited by 2,283
The interaction between bacteria and bile
Begley, M., Gahan, C. G. M., & Hill, C. (2005) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2004.09.003 · Cited by 1,790
“However, according to some authors, BSH activity of probiotics would not be favourable as subsequent modification of unconjugated bile salts could generate toxic compounds, which could disturb the normal microbiota of the gut leading to diarrhoea, mucosal inflammation or activation of carcinogens in the intestinal con…”
BackgroundProbiotics and their fermented food products are beneficial for health
Parvez, S., Malik, K. A., Ah Kang, S., & Kim, H.-Y. (2006) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2006.02963.x · Cited by 1,435
“thermophilus (Hilton et al. 1977; Savaiano and Levitt 1987; Isolauri et al. 1991; Saavedra et al. 1994; Salminen et al. 1996; Saxelin 1997; Aiba et al. 1998; Gionchetti et al. 2000a; Gorbach 2000; Pochapin 2000; Shanahan 2001; Solga 2003; Tomas et al. 2004).”
BackgroundFunctional food science and gastrointestinal physiology and function
Salminen, S., Bouley, C., Boutron, M.-C., Cummings, J. H., Franck, A., Gibson, G. R., Isolauri, E., Moreau, M.-C., Roberfroid, M., & Rowland, I. (1998) · British Journal of Nutrition · doi:10.1079/bjn19980108 · Cited by 1,398
Self-citationThe role and application of enterococci in food and health
Foulquié Moreno, M. R., Sarantinopoulos, P., Tsakalidou, E., & De Vuyst, L. (2006) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2005.06.026 · Cited by 1,080
“A group of requirements have been identified for a microorganism to be defined as an effective probiotic (Salminen et al., 1996).”
Background
Metadata
- Authors
- Salminen, S., Isolauri, E., & Salminen, E.
- Affiliations
- University of Turku (FI)
- University of Tampere (FI)
- Turku University Hospital (FI)
- Venue
- Antonie van Leeuwenhoek
- Published
- 1996-10
- Volume
- 70
- Issue
- 2-4
- Pages
- 347-358
- ISSN
- 0003-6072 (ISSN-L)
- 1572-9699
- OpenAlex
- W1981462868
- Cited by
- 406
- References
- 79
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 8 · 2023: 7 · 2022: 7 · 2021: 14 · 2020: 12 · 2019: 8 · 2018: 10 · 2017: 11 · 2016: 14 · 2015: 12 · 2014: 19 · 2013: 17 · 2012: 15
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Antonie van Leeuwenhoek (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- probiotics, gut mucosal barrier, intestinal permeability, gut microbiota, rotavirus gastroenteritis, food allergy, colonic diseases, pelvic radiotherapy, colon cancer, intestinal inflammation, probiotic strain selection, intestinal colonization, functional foods
- MeSH terms
- Animals, Bacterial Adhesion, Bifidobacterium, Child, Food Hypersensitivity, Food, Formulated, Gastroenteritis, Humans, Intestinal Mucosa, Lactobacillus, Permeability, Rotavirus Infections, Bacterial Physiological Phenomena, Immunity, Mucosal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges. https://app.cochat.ai/papers/10.1007/bf00395941
- The paper
- Salminen, S., Isolauri, E., & Salminen, E. (1996). Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges. Antonie van Leeuwenhoek. https://doi.org/10.1007/bf00395941
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.